Joint Health Study

Launched by AUBURN UNIVERSITY · Jun 28, 2022

Keywords

ClinConnect Summary

The Joint Health Study is examining whether a natural supplement called calcium fructoborate (CFB) can help relieve joint discomfort, particularly for people suffering from knee osteoarthritis. This study is looking for participants aged 40 to 65 who have been experiencing chronic knee pain for over three months. To be eligible, individuals should not be on any joint health supplements or pain medications, and they must have reliable internet access and some basic computer skills to participate in this virtual study.

Participants will be randomly assigned to take either CFB or a placebo (a harmless substance with no active ingredients) every day for 90 days. Throughout the study, researchers will monitor any changes in joint discomfort. It's important to note that participants with certain health conditions, like diabetes or rheumatoid arthritis, cannot join. This trial is a great opportunity for those looking for potential relief from joint pain through a natural approach!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Between 40-65 years of age;
• • 2. Self-reported or medically diagnosed knee joint pain for \> 3 months (chronic);
• • 3. Diagnosis of osteoarthritis of the knee;
• • 4. No diagnosed psychiatric or neurological condition;
• • 5. Not taking antibiotics;
• • 6. Not taking any other joint health supplement
• • 7. Not taking prescription medications for OA or joint discomfort for the last 3 months
• • 8. No use of NSAIDS or other pain relievers for two (2) weeks prior to enrollment in the study and who are willing to make best efforts to refrain from use of same throughout the study
• • 9. Has reliable internet service;
• • 10. Some computer literacy;
• • 11. Has a smartphone; and
• • 12. Has a laptop, desktop computer, or iPad.
• Exclusion Criteria:
• • 1. \<40 or \>65 years of age;
• • 2. Does not have osteoarthritis of the knee;
• • 3. Diabetes or other metabolic disorders;
• • 4. Inflammatory and/or infectious health conditions;
• • 6) Participants medically diagnosed with rheumatoid arthritis; 7) Participants with cardiovascular diseases; 8) Participants with liver and/or kidney problems; 9) Participants who are pregnant; 10) Health conditions that would prevent the participant from successfully completing the study (i.e., motor control conditions such as Parkinson's; psychiatric conditions such as ADHD); 11) Use of antibiotics 1 month prior to the enrollment in the study; 12) Physician prescribed use of pharmaceutical medications for OA or joint discomfort within 3 months prior to enrollment in this study; 13) Any joint injury in the 6-months prior to the enrollment in the clinical trial; 14) Unreliable or no internet access/service; 15) Unable to use a smartphone or lacking the computer literacy needed to complete the study 16) No laptop, desktop, or iPad that would allow for the completion of the study tasks.